Detalles de la búsqueda
1.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Ann Hematol
; 102(3): 547-561, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695874
2.
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Ann Hematol
; 100(9): 2387-2398, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34232360
3.
Correction to: Allogeneic hematopoietic stem cell transplantation improves longterm outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Ann Hematol
; 100(11): 2877-2878, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34529106
4.
JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse.
Haematologica
; 98(5): 722-8, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23300178
5.
No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group.
Leuk Lymphoma
; 61(12): 2821-2830, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32672489
6.
Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia.
Haematologica
; 93(6): 826-33, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18469349
7.
Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
Haematologica
; 92(6): 763-70, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17550848
8.
Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).
J Cancer Res Clin Oncol
; 143(10): 2049-2058, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28534173
9.
The effect of prior exposure to imatinib on transplant-related mortality.
Haematologica
; 91(4): 452-9, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16585011
10.
Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy.
Haematologica
; 89(1): 49-57, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14754606
11.
High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib.
Hematol J
; 5(1): 55-60, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-14745431
12.
Intermediate-dose cytarabine treatment delivered at moderate infusion rates for de novo acute myeloid leukemia-results of a phase I-II study.
Leuk Lymphoma
; 43(2): 265-74, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11999557
13.
Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia.
Leuk Lymphoma
; 55(6): 1274-80, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23964650
14.
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.
J Cancer Res Clin Oncol
; 140(11): 1947-56, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24942335
15.
Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia.
Onco Targets Ther
; 6: 741-8, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23836986
16.
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.
J Cancer Res Clin Oncol
; 139(3): 499-508, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23184429
17.
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.
J Cancer Res Clin Oncol
; 139(11): 1937-46, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24046251
18.
Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation.
Am J Blood Res
; 2(4): 243-53, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23226624
19.
Delayed processing of bone marrow samples reveals a prognostic pattern of NME mRNA expression in cytogenetically normal acute myeloid leukemia.
Leuk Lymphoma
; 53(8): 1561-8, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22421058
20.
Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study.
Leuk Lymphoma
; 53(1): 110-7, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21767242